Free Content Analysis of Diacetylmorphine, Caffeine, and Degradation Products after Volatilization of Pharmaceutical Heroin for Inhalation

Authors: Klous, Marjolein G.1; Lee, WeiChing1; Hillebrand, Michel J.X.1; van den Brink, Wim2; van Ree, Jan M.3; Beijnen, Jos H.4

Source: Journal of Analytical Toxicology, Volume 30, Number 1, January/February 2006 , pp. 6-13(8)

Publisher: Preston Publications

Buy & download fulltext article:

Free content The full text is free.

View now:
PDF 180.1kb 

Abstract:

Pharmaceutical smokable heroin was developed for a clinical trial on medical co-prescription of heroin and methadone. This product, consisting of 75% w/w diacetylmorphine base and 25% w/w caffeine anhydrate, was intended for use via “chasing the dragon”, that is, inhalation after volatilization. This procedure involves heating the powder mixture, which may lead to formation of degradation products that could subsequently be inhaled. We developed a method that used a high-performance liquid chromatography system that was compatible with photodiode-array detection and mass spectrometric detection to separate diacetylmorphine- and caffeine-related compounds in a wide polarity range for analysis of the vapor. This method was used to analyze the contents of the plastic drinking straws that were used by patients to inhale the vapors from pharmaceutical heroin used via chasing the dragon, which were considered to be representative of the vapors the patients inhaled. They contained primarily unchanged diacetylmorphine, its main metabolite 6-acetylmorphine, caffeine, and some morphine. Several unidentified peaks were observed in the straw chromatograms. Chemical structures were proposed for nine degradation products: morphine derivatives with different substitution patterns of the C3, C6, and/or N17 positions, which comprised 0.4–9.7% of the straw sample residue weight. Activity and toxicity of most of these compounds are unknown and require further investigation.

Document Type: Research article

Affiliations: 1: Slotervaart Hospital, Department of Pharmacy and Pharmacology, Amsterdam, The Netherlands 2: Central Committee on the Treatment of Heroin Addicts, Utrecht, The Netherlands; and Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands 3: Central Committee on the Treatment of Heroin Addicts, Utrecht, The Netherlands; and Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and Anatomy, University Medical Centre Utrecht, Utrecht, The Netherlands 4: Slotervaart Hospital, Department of Pharmacy and Pharmacology, Amsterdam, The Netherlands; and Utrecht University, Faculty of Pharmaceutical Sciences, Utrecht, The Netherlands

Publication date: 2006-01-01

More about this publication?
  • The Journal of Analytical Toxicology (JAT), established in 1977 and published 9 times a year, is the international source covering a broad range of clinical, forensic, and industrial laboratory topics regarding the isolation, identification, and quantitation of potentially toxic substances.

    With an emphasis on practical application, JAT articles provide improved and novel techniques for use in clinical, forensic, workplace, sports testing (doping), and other toxicology laboratories. Articles describe newly developed methods in immunoassay testing, gas chromatography, liquid chromatography, mass spectrometry, atomic absorption spectrometry, solid and liquid phase extraction techniques, and other analytical approaches. Worldwide readership includes toxicologists, pathologists, chemists, clinicians, researchers, and educators working in medical examiner and law enforcement laboratories, hospitals, university and independent analytical laboratories, as well as the drug manufacturing industry.

    Each year in October, we publish a special issue from the Society of Forensic Toxicologists.

    JAT, as determined by ISI Citation Index, is one of the two most referenced international journals in forensic science.

  • Subscribe to this Title
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page